Informações:
Falhas:
ID
26828
Descrição
Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00895414
Link
https://clinicaltrials.gov/show/NCT00895414
Palavras-chave
Versões (1)
- 25/10/2017 25/10/2017 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
25 de outubro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT00895414
Eligibility Breast Cancer NCT00895414
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00895414
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Breast Carcinoma
Item
tissue diagnosis of a breast carcinoma
boolean
C0678222 (UMLS CUI [1])
Doxorubicin | Chemotherapy Regimen
Item
the oncologist must have prescribed doxorubicin as part of the planned chemotherapy regimen
boolean
C0013089 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
Organ function
Item
have acceptable organ function within 14 days of enrollment defined as:
boolean
C0678852 (UMLS CUI [1])
Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
liver function: total bilirubin, ast and alt within normal institutional limits
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
Renal function | Estimation of creatinine clearance by Cockcroft-Gault formula | Creatinine clearance measurement | Gender
Item
kidney function: estimated creatinine clearance > 60 ml/min calculated creatinine clearance (for females) - formula: (140 - age) x weight x .85 divided by (scr x 72)
boolean
C0232804 (UMLS CUI [1])
C2711451 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
C0079399 (UMLS CUI [4])
C2711451 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
C0079399 (UMLS CUI [4])
Age
Item
at least 18 years old
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
patient must have given written informed consent indicating an understanding of the investigational nature of the study
boolean
C0021430 (UMLS CUI [1])
GRAPEFRUIT JUICE Consumption Abstinence
Item
agrees not to consume grapefruit juice while on the study
boolean
C0452456 (UMLS CUI [1,1])
C0009830 (UMLS CUI [1,2])
C3843422 (UMLS CUI [1,3])
C0009830 (UMLS CUI [1,2])
C3843422 (UMLS CUI [1,3])
Enalapril allergy
Item
known allergy to enalapril
boolean
C0571946 (UMLS CUI [1])
Cytochrome P450 3A4 Inducer | Cytochrome P450 3A4 Inhibitor
Item
taking any known p450 cytochrome inducers or inhibitors
boolean
C3830625 (UMLS CUI [1])
C3830624 (UMLS CUI [2])
C3830624 (UMLS CUI [2])
Herbal supplement
Item
taking any herbal supplements while on the study or the week prior to receiving doxorubicin
boolean
C1504473 (UMLS CUI [1])
ACE Inhibitors | Angiotensin II receptor antagonist
Item
taking an ace-inhibitor or angiotensin receptor blocker
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C0521942 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or lactating. enalapril is pregnancy categories c (first trimester) and d (second and third trimesters)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])